Skip to main content
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRS ISIN · US00461U1051 LEI · 5493000B2LQ9QTW1DF52 US Manufacturing
Filings indexed 844 across all filing types
Latest filing 2024-06-07 Declaration of Voting R…
Country US United States of America
Listing US ACRS

About Aclaris Therapeutics, Inc.

https://www.aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC by Aclaris Therapeutics, Inc. dated June 6, 2024. The key content is the submission of matters to a vote of security holders at the company's 2024 annual meeting, including election of directors, advisory approval of executive compensation, and ratification of the independent auditor. The document provides detailed voting results for these proposals. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document is not an Annual Report, Proxy Statement, or Management Report, but specifically reports voting outcomes. The length (4531 characters) and content confirm it is a voting results announcement rather than a full report or proxy solicitation material.
2024-06-07 English
Director's Dealing 2024
Director's Dealing
2024-06-04 English
Director's Dealing 2024
Director's Dealing
2024-06-04 English
Director's Dealing 2024
Director's Dealing
2024-06-04 English
Director's Dealing 2024
Director's Dealing
2024-06-04 English
Director's Dealing 2024
Director's Dealing
2024-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.